메뉴 건너뛰기




Volumn 23, Issue 2, 2012, Pages 230-238

A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma

Author keywords

chemotherapy; cisplatin; gemcitabine; long infusion; malignant pleural mesothelioma

Indexed keywords

APREPITANT; CISPLATIN; GEMCITABINE; GRANISETRON; LOW MOLECULAR WEIGHT HEPARIN; METOCLOPRAMIDE;

EID: 84855210829     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32834d7a1c     Document Type: Article
Times cited : (33)

References (58)
  • 1
    • 23044436187 scopus 로고    scopus 로고
    • Malignant mesothelioma
    • DOI 10.1016/S0140-6736(05)67025-0, PII S0140673605670250
    • Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005; 366:397-408. (Pubitemid 41073959)
    • (2005) Lancet , vol.366 , Issue.9483 , pp. 397-408
    • Robinson, B.W.S.1    Musk, A.W.2    Lake, R.A.3
  • 3
    • 63949087814 scopus 로고    scopus 로고
    • Occupational, domestic and environmental mesothelioma risks in the British population: A case-control study
    • Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: A case-control study. Br J Cancer 2009; 100:1175-1183.
    • (2009) Br J Cancer , vol.100 , pp. 1175-1183
    • Rake, C.1    Gilham, C.2    Hatch, J.3    Darnton, A.4    Hodgson, J.5    Peto, J.6
  • 4
    • 67650002101 scopus 로고    scopus 로고
    • Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma
    • Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009; 27:3007-3013.
    • (2009) J Clin Oncol , vol.27 , pp. 3007-3013
    • Krug, L.M.1    Pass, H.I.2    Rusch, V.W.3    Kindler, H.L.4    Sugarbaker, D.J.5    Rosenzweig, K.E.6
  • 5
    • 78149450949 scopus 로고    scopus 로고
    • Malignant pleural mesothelioma. A population-based study of survival
    • Milano MT, Zhang H. Malignant pleural mesothelioma. A population-based study of survival. J Thorac Oncol 2010; 5:1841-1848.
    • (2010) J Thorac Oncol , vol.5 , pp. 1841-1848
    • Milano, M.T.1    Zhang, H.2
  • 7
    • 0002117722 scopus 로고    scopus 로고
    • Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma: A phase II study of the GSTPV
    • Aversa SM, Favaretto AG. Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma: A phase II study of the GSTPV. Clin Lung Cancer 1999; 1:73-77.
    • (1999) Clin Lung Cancer , vol.1 , pp. 73-77
    • Aversa, S.M.1    Favaretto, A.G.2
  • 9
    • 0037183683 scopus 로고    scopus 로고
    • A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
    • Nowak AK, Byrne MJ, Williamson R, Ryan G, Segal A, Fielding D, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002; 87:491-496.
    • (2002) Br J Cancer , vol.87 , pp. 491-496
    • Nowak, A.K.1    Byrne, M.J.2    Williamson, R.3    Ryan, G.4    Segal, A.5    Fielding, D.6
  • 12
    • 42949152330 scopus 로고    scopus 로고
    • Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)
    • DOI 10.1016/j.lungcan.2007.09.018, PII S0169500207005636
    • Kalmadi SR, Rankin C, Kraut MJ, Jacobs AD, Petrylak DP, Adelstein DJ, et al. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810). Lung Cancer 2008; 60:259-263. (Pubitemid 351609140)
    • (2008) Lung Cancer , vol.60 , Issue.2 , pp. 259-263
    • Kalmadi, S.R.1    Rankin, C.2    Kraut, M.J.3    Jacobs, A.D.4    Petrylak, D.P.5    Adelstein, D.J.6    Keohan, M.L.7    Taub, R.N.8    Borden, E.C.9
  • 13
    • 0031406423 scopus 로고    scopus 로고
    • A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
    • DOI 10.1023/A:1005981317532
    • Brand R, Capadano M, Tempero M. A phase I trial of weekly gemcitabine administered as prolonged infusion in patients with pancreatic cancer and other solid tumors. Invest New Drugs 1997; 15:331-341. (Pubitemid 28098500)
    • (1997) Investigational New Drugs , vol.15 , Issue.4 , pp. 331-341
    • Brand, R.1    Capadano, M.2    Tempero, M.3
  • 15
    • 0031734416 scopus 로고    scopus 로고
    • Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors
    • DOI 10.1023/A:1008487932384
    • Touroutoglou N, Gravel D, Raber MN, Plunkett W, Abbruzzese JL. Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors. Ann Oncol 1998; 9: 1003-1008. (Pubitemid 28496710)
    • (1998) Annals of Oncology , vol.9 , Issue.9 , pp. 1003-1008
    • Touroutoglou, N.1    Gravel, D.2    Raber, M.N.3    Plunkett, W.4    Abbruzzese, J.L.5
  • 16
    • 0030035730 scopus 로고    scopus 로고
    • A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer
    • Anderson H, Thatcher N, Walling J, Hansen H. A phase I study of a 24 h infusion of gemcitabine in previously untreated patients with inoperable nonsmall-cell lung cancer. Br J Cancer 1996; 74:460-462. (Pubitemid 26254579)
    • (1996) British Journal of Cancer , vol.74 , Issue.3 , pp. 460-462
    • Anderson, H.1    Thatcher, N.2    Walling, J.3    Hansen, H.4
  • 20
    • 0026101039 scopus 로고
    • Saturation of 20,20-difluorodeoxycytidine 50-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine
    • Grunewald R, Abbruzzese JL, Tarassoff P, Plunkett W. Saturation of 20,20-difluorodeoxycytidine 50-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine. Cancer Chemother Pharmacol 1991; 27:258-262.
    • (1991) Cancer Chemother Pharmacol , vol.27 , pp. 258-262
    • Grunewald, R.1    Abbruzzese, J.L.2    Tarassoff, P.3    Plunkett, W.4
  • 22
    • 33745621338 scopus 로고    scopus 로고
    • Pharmacokinetic evaluation of gemcitabine and 2′,2′- difluorodeoxycytidine-5′-triphosphate after prolonged infusion in patients affected by different solid tumors
    • DOI 10.1093/annonc/mdj970
    • Cattel L, Airoldi M, Delprino L, Passera R, Milla P, Pedani F. Pharmacokinetic evaluation of gemcitabine and 20,20-difluorodeoxycytidine-50- triphosphate after prolonged infusion in patients affected by different solid tumors. Ann Oncol 2006; 17 (Suppl 5):v142-v147. (Pubitemid 43985224)
    • (2006) Annals of Oncology , vol.17 , Issue.SUPPL. 5
    • Cattel, L.1    Airoldi, M.2    Delprino, L.3    Passera, R.4    Milla, P.5    Pedani, F.6
  • 23
    • 42949093133 scopus 로고    scopus 로고
    • Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
    • DOI 10.1016/j.lungcan.2007.10.004, PII S0169500207006083
    • Xiong JP, Feng M, Qiu F, Xu J, Tao QS, Zhang L, et al. Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer. Lung Cancer 2008; 60:208-214. (Pubitemid 351609148)
    • (2008) Lung Cancer , vol.60 , Issue.2 , pp. 208-214
    • Xiong, J.P.1    Feng, M.2    Qiu, F.3    Xu, J.4    Tao, Q.S.5    Zhang, L.6    Xiang, X.J.7    Zhong, L.X.8    Yu, F.9    Ma, X.T.10    Gong, W.Y.11
  • 24
    • 69549143754 scopus 로고    scopus 로고
    • Treatment of advanced NSCLC (Stage IIIB and IV) with low dose gemcitabine and carboplatin [Abstract]
    • Parikh PM, Narayanan P, Mistry RC, Agarwal JP, Pai VR, Nair R, et al. Treatment of advanced NSCLC (Stage IIIB and IV) with low dose gemcitabine and carboplatin [Abstract]. J Clin Oncol 2005; 23 (Suppl 1):196 S.
    • (2005) J Clin Oncol , vol.23 , Issue.SUPPL. 1
    • Parikh, P.M.1    Narayanan, P.2    Mistry, R.C.3    Agarwal, J.P.4    Pai, V.R.5    Nair, R.6
  • 25
    • 0033911963 scopus 로고    scopus 로고
    • Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas
    • DOI 10.1097/00001813-200006000-00002
    • Spath-Schwalbe E, Genvresse I, Koschuth A, Dietzmann A, Grunewald R, Possinger K. Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas. Anticancer Drugs 2000; 11:325-329. (Pubitemid 30459467)
    • (2000) Anti-Cancer Drugs , vol.11 , Issue.5 , pp. 325-329
    • Spath-Schwalbe, E.1    Genvresse, I.2    Koschuth, A.3    Dietzmann, A.4    Grunewald, R.5    Possinger, K.6
  • 26
    • 0035090424 scopus 로고    scopus 로고
    • Achievement of complete remission in refractory Hodgkin's disease with prolonged infussion of gemcitabine
    • DOI 10.1023/A:1006478702342
    • Sezer O, Eucker J, Jakob C, Kaufmann O, Schmid P, Possinger K. Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine. Invest New Drugs 2001; 19:101-104. (Pubitemid 32209792)
    • (2001) Investigational New Drugs , vol.19 , Issue.1 , pp. 101-104
    • Sezer, O.1    Eucker, J.2    Jakob, C.3    Kaufmann, O.4    Schmid, P.5    Possinger, K.6
  • 28
    • 0242665443 scopus 로고    scopus 로고
    • Phase II Trial of a 24-Hour Infusion of Gemcitabine in Previously Untreated Patients with Advanced Pancreatic Adenocarcinoma
    • DOI 10.1081/CNV-120023767
    • Eckel F, Schmelz R, Erdmann J, Mayr M, Lersch C. Phase II trial of a 24-h infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma. Cancer Invest 2003; 21:690-694. (Pubitemid 37377323)
    • (2003) Cancer Investigation , vol.21 , Issue.5 , pp. 690-694
    • Eckel, F.1    Schmelz, R.2    Erdmann, J.3    Mayr, M.4    Lersch, C.5
  • 30
    • 27644595794 scopus 로고    scopus 로고
    • Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
    • DOI 10.1097/00001813-200511000-00013
    • Zwitter M, Kovac V, Smrdel U, Kocijancic I, Segedin B, Vrankar M. Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer. Anticancer Drugs 2005; 16: 1129-1134. (Pubitemid 41565779)
    • (2005) Anti-Cancer Drugs , vol.16 , Issue.10 , pp. 1129-1134
    • Zwitter, M.1    Kovac, V.2    Smrdel, U.3    Kocijancic, I.4    Segedin, B.5    Vrankar, M.6
  • 31
    • 69549116226 scopus 로고    scopus 로고
    • Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: A randomized phase II clinical trial
    • Zwitter M, Kovac V, Smrdel U, Vrankar M, Zadnik V. Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: A randomized phase II clinical trial. J Thorac Oncol 2009; 4:1148-1155.
    • (2009) J Thorac Oncol , vol.4 , pp. 1148-1155
    • Zwitter, M.1    Kovac, V.2    Smrdel, U.3    Vrankar, M.4    Zadnik, V.5
  • 32
    • 77953539831 scopus 로고    scopus 로고
    • Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: A phase II randomized trial
    • Zwitter M, Kovac V, Rajer M, Vrankar M, Smrdel U. Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: A phase II randomized trial. Anticancer Drugs 2010; 21:662-668.
    • (2010) Anticancer Drugs , vol.21 , pp. 662-668
    • Zwitter, M.1    Kovac, V.2    Rajer, M.3    Vrankar, M.4    Smrdel, U.5
  • 33
    • 2442418050 scopus 로고    scopus 로고
    • Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy
    • Socinski MA. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy. Clin Lung Cancer 2004; 5:274-289. (Pubitemid 38618238)
    • (2004) Clinical Lung Cancer , vol.5 , Issue.5 , pp. 274-289
    • Socinski, M.A.1
  • 34
    • 79952265014 scopus 로고    scopus 로고
    • Pleural mesothelioma
    • UICC International Union Against Cancer, editor. 7th ed Chichester: Wiley-Blackwell.
    • Sobin LH, Gospodarowicz MK, Wittekind Ch. Pleural mesothelioma. In: UICC International Union Against Cancer, editor. TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell. 2009; pp. 147-150.
    • (2009) TNM Classification of Malignant Tumours , pp. 147-150
    • Sobin, L.H.1    Gospodarowicz, M.K.2    Wittekind, C.3
  • 35
    • 1342267614 scopus 로고    scopus 로고
    • Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
    • DOI 10.1093/annonc/mdh059
    • Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15:257-260. (Pubitemid 38262625)
    • (2004) Annals of Oncology , vol.15 , Issue.2 , pp. 257-260
    • Byrne, M.J.1    Nowak, A.K.2
  • 36
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • DOI 10.1016/0197-2456(89)90015-9
    • Simon R. Optimal designs for phase II clinical trials. Control Clin Trials 1989; 10:1-10. (Pubitemid 19099520)
    • (1989) Controlled Clinical Trials , vol.10 , Issue.1 , pp. 1-10
    • Simon, R.1
  • 39
    • 27244447448 scopus 로고    scopus 로고
    • Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
    • Van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 2005; 23:6881-6889.
    • (2005) J Clin Oncol , vol.23 , pp. 6881-6889
    • Van Meerbeeck, J.P.1    Gaafar, R.2    Manegold, C.3    Van Klaveren, R.J.4    Van Marck, E.A.5    Vincent, M.6
  • 40
    • 43249105802 scopus 로고    scopus 로고
    • Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
    • Jassem J, Ramlau R, Santoro A, Schuette W, Chemaissani A, Hong S, et al. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 2008; 26:1698-1704.
    • (2008) J Clin Oncol , vol.26 , pp. 1698-1704
    • Jassem, J.1    Ramlau, R.2    Santoro, A.3    Schuette, W.4    Chemaissani, A.5    Hong, S.6
  • 42
    • 58949097246 scopus 로고    scopus 로고
    • Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: A phase II study
    • Hillerdal G, Sorensen JB, Sundström S, Riska H, Vikström A, Hjerpe A. Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: A phase II study. J Thorac Oncol 2008; 3:1325-1331.
    • (2008) J Thorac Oncol , vol.3 , pp. 1325-1331
    • Hillerdal, G.1    Sorensen, J.B.2    Sundström, S.3    Riska, H.4    Vikström, A.5    Hjerpe, A.6
  • 43
    • 50349092664 scopus 로고    scopus 로고
    • Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: Results of the International Expanded Access Program
    • Santoro A, O'Brien ME, Stahel RA, Nackaerts K, Baas P, Karthaus M, et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: Results of the International Expanded Access Program. J Thorac Oncol 2008; 3:756-763.
    • (2008) J Thorac Oncol , vol.3 , pp. 756-763
    • Santoro, A.1    O'Brien, M.E.2    Stahel, R.A.3    Nackaerts, K.4    Baas, P.5    Karthaus, M.6
  • 44
    • 70349687645 scopus 로고    scopus 로고
    • The mesothelioma and radical surgery randomized controlled trial: The Mars feasibility study
    • Treasure T, Waller D, Tan C, Entwisle J, O'Brien M, O'Byrne K, et al. The mesothelioma and radical surgery randomized controlled trial: The Mars feasibility study. J Thorac Oncol 2009; 4:1254-1258.
    • (2009) J Thorac Oncol , vol.4 , pp. 1254-1258
    • Treasure, T.1    Waller, D.2    Tan, C.3    Entwisle, J.4    O'Brien, M.5    O'Byrne, K.6
  • 46
    • 84855208311 scopus 로고    scopus 로고
    • Cancer Registry of Republic of Slovenia. Ljubljana: Institute of Oncology Ljubljana
    • Cancer Registry of Republic of Slovenia. Cancer incidence in Slovenia 2002-2008. Ljubljana: Institute of Oncology Ljubljana; 2005-2011.
    • (2005) Cancer incidence in Slovenia 2002-2008
  • 47
    • 79951772961 scopus 로고    scopus 로고
    • A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria
    • Tsao AS, Garland L, Redman M, Kernstine K, Gandara D, Marom EM. A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria. J Thorac Oncol 2011; 6:598-601.
    • (2011) J Thorac Oncol , vol.6 , pp. 598-601
    • Tsao, A.S.1    Garland, L.2    Redman, M.3    Kernstine, K.4    Gandara, D.5    Marom, E.M.6
  • 48
    • 0031961891 scopus 로고    scopus 로고
    • Prognostic factors in patients with pleural mesothelioma: The European organization for research and treatment of cancer experience
    • Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G. Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998; 16:145-152. (Pubitemid 28041592)
    • (1998) Journal of Clinical Oncology , vol.16 , Issue.1 , pp. 145-152
    • Curran, D.1    Sahmoud, T.2    Therasse, P.3    Van Meerbeeck, J.4    Postmus, P.E.5    Giaccone, G.6
  • 49
    • 58149083475 scopus 로고    scopus 로고
    • Systemic treatments for mesothelioma: Standard and novel
    • Kindler HL. Systemic treatments for mesothelioma: Standard and novel. Curr Treat Options Oncol 2008; 9:171-179.
    • (2008) Curr Treat Options Oncol , vol.9 , pp. 171-179
    • Kindler, H.L.1
  • 50
    • 77249101787 scopus 로고    scopus 로고
    • Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: A phase II study
    • Katirtzoglou N, Gkiozos I, Makrilia N, Tsaroucha E, Rapti A, Stratakos G, et al. Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: A phase II study. Clin Lung Cancer 2010; 11:30-35.
    • (2010) Clin Lung Cancer , vol.11 , pp. 30-35
    • Katirtzoglou, N.1    Gkiozos, I.2    Makrilia, N.3    Tsaroucha, E.4    Rapti, A.5    Stratakos, G.6
  • 51
    • 70349454095 scopus 로고    scopus 로고
    • Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma
    • Wilcox BE, Subramaniam RM, Peller PJ, Aughenbaugh GL, Nichols Iii FC, Aubry MC, et al. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer 2009; 10:244-248.
    • (2009) Clin Lung Cancer , vol.10 , pp. 244-248
    • Wilcox, B.E.1    Subramaniam, R.M.2    Peller, P.J.3    Aughenbaugh, G.L.4    Nichols Iii, F.C.5    Aubry, M.C.6
  • 52
    • 77951807217 scopus 로고    scopus 로고
    • Chemotherapy induced pathologic complete response in malignant pleural mesothelioma: A review and case report
    • Bech C, Sørensen JB. Chemotherapy induced pathologic complete response in malignant pleural mesothelioma: A review and case report. J Thorac Oncol 2010; 5:735-740.
    • (2010) J Thorac Oncol , vol.5 , pp. 735-740
    • Bech, C.1    Sørensen, J.B.2
  • 56
    • 68549106008 scopus 로고    scopus 로고
    • Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: A single institution phase II study
    • Ralli M, Tourkantonis I, Makrilia N, Gkini E, Kotteas E, Gkiozos I, et al. Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: A single institution phase II study. Anticancer Res 2009; 29:3441-3444.
    • (2009) Anticancer Res , vol.29 , pp. 3441-3444
    • Ralli, M.1    Tourkantonis, I.2    Makrilia, N.3    Gkini, E.4    Kotteas, E.5    Gkiozos, I.6
  • 57
    • 46349111832 scopus 로고    scopus 로고
    • Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
    • DOI 10.1038/sj.bjc.6604421, PII 6604421
    • Sørensen JB, Frank H, Palshof T. Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma. Br J Cancer 2008; 99:44-50. (Pubitemid 351920221)
    • (2008) British Journal of Cancer , vol.99 , Issue.1 , pp. 44-50
    • Sorensen, J.B.1    Frank, H.2    Palshof, T.3
  • 58
    • 67349198885 scopus 로고    scopus 로고
    • Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: A review of practice in British Columbia
    • Lee CW, Murray N, Anderson H, Rao SC, Bishop W. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: A review of practice in British Columbia. Lung Cancer 2009; 64:308-313.
    • (2009) Lung Cancer , vol.64 , pp. 308-313
    • Lee, C.W.1    Murray, N.2    Anderson, H.3    Rao, S.C.4    Bishop, W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.